Copyright
©The Author(s) 2016.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 97-101
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.97
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.97
IA | Tumour confined to the vulva or perineum, ≤ 2 cm in size with stromal invasion ≤ 1 mm, negative nodes |
IB | Tumour confined to the vulva or perineum, > 2 cm in size or with stromal invasion > 1 mm, negative nodes |
II | Tumour of any size with adjacent spread (1/3 lower urethra, 1/3 lower vagina, anus), negative nodes |
IIIA | Tumour of any size with positive inguino-femoral lymph nodes |
(1) 1 lymph node metastasis greater than or equal to 5 mm | |
(2) 1-2 lymph node metastasis(es) of less than 5 mm | |
IIIB | (1) 2 or more lymph nodes metastases greater than or equal to 5 mm |
(2) 3 or more lymph nodes metastases less than 5 mm | |
IIIC | Positive node(s) with extracapsular spread |
IVA | (1) Tumour invades other regional structures (2/3 upper urethra, 2/3 upper |
vagina), bladder mucosa, rectal mucosa, or fixed to pelvic bone | |
(2) Fixed or ulcerated inguino-femoral lymph nodes | |
IVB | Any distant metastasis including pelvic lymph nodes |
- Citation: Platt SL, Manley KM, Murdoch JB. Review of the current surgical management of vulval cancer. World J Obstet Gynecol 2016; 5(1): 97-101
- URL: https://www.wjgnet.com/2218-6220/full/v5/i1/97.htm
- DOI: https://dx.doi.org/10.5317/wjog.v5.i1.97